Institute of Anatomy, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Invest Ophthalmol Vis Sci. 2011 Aug 29;52(9):6807-13. doi: 10.1167/iovs.11-7710.
To evaluate retroviral vectors as a tool to transduce normal human corneal endothelial cells (HCECs) and to optimize transduction to increase gene transfer efficiency.
Enhanced green fluorescent protein (EGFP) encoding retroviral vectors based on HIV-1 or murine leukemia virus (MLV), pseudotyped with either vesicular stomatitis virus glycoprotein (VSV-G) or a modified foamy virus envelope protein (FV Env), and prototype foamy virus (PFV) were produced. Transduction was performed in four HCEC culture media that were previously described for specific cultivation of HCECs or organ culture of donor corneas, namely enriched HCEC growth medium F99(HCEC), its unsupplemented basal medium F99, MEM + 2% fetal calf serum (FCS) (MEM), and Human Endothelial-SFM (SFM). Transduction efficiency was evaluated by marker gene transfer assay, and cytotoxic effects of virus infection were evaluated by means of resazurin conversion assay.
PFV- and HIV-1-based vectors showed superior transduction efficiency compared with MLV-based vectors. Pseudotyping with a modified FV Env increased transduction efficiency compared with pseudotyping with VSV-G. In medium SFM, transduction efficiency of PFV, HIV-1-/FV Env, and MLV-based vectors was markedly reduced compared with the other culture media. When cells were cultured in F99-based media, cell viability was reduced by retroviral transduction compared with uninfected or mock infected controls, but remained unaffected when cells were cultured in SFM and was even increased when cells were cultured in MEM.
HIV-1-based vectors pseudotyped with FV Env can efficiently be used to transduce primary HCECs in vitro. However, transduction efficiency is dependent on culture conditions and impairs metabolic activity and viability of HCECs in vitro.
评估逆转录病毒载体作为转导正常人类角膜内皮细胞(HCEC)的工具,并优化转导以提高基因转移效率。
生产了基于 HIV-1 或鼠白血病病毒(MLV)的编码增强型绿色荧光蛋白(EGFP)的逆转录病毒载体,其假型为水疱性口炎病毒糖蛋白(VSV-G)或改良的泡沫病毒包膜蛋白(FV Env),以及原型泡沫病毒(PFV)。在之前描述的用于特定培养 HCEC 或供体角膜器官培养的四种 HCEC 培养基中进行转导,即富含 HCEC 生长培养基 F99(HCEC)、其未补充的基础培养基 F99、MEM+2%胎牛血清(FCS)(MEM)和 Human Endothelial-SFM(SFM)。通过标记基因转移测定评估转导效率,并通过 Resazurin 转化测定评估病毒感染的细胞毒性作用。
与 MLV 为基础的载体相比,PFV 和 HIV-1 为基础的载体显示出更高的转导效率。与使用 VSV-G 假型相比,使用改良的 FV Env 假型增加了转导效率。在 SFM 培养基中,与其他培养介质相比,PFV、HIV-1/FV Env 和 MLV 为基础的载体的转导效率明显降低。当细胞在基于 F99 的培养基中培养时,与未感染或模拟感染对照相比,逆转录病毒转导降低了细胞活力,但在 SFM 中培养时不受影响,而在 MEM 中培养时甚至增加。
基于 HIV-1 的载体,假型化为 FV Env,可以有效地在体外转导原代 HCEC。然而,转导效率取决于培养条件,并损害 HCEC 的代谢活性和体外活力。